| Companies sponsors |
Eli Lilly and Company (donanemab) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| |
UCL Dementia Research Centre |
| Patient carer groups |
Alzheimer’s Research UK |
| |
Alzheimer's Society |
| |
Dementia UK |
| Professional groups |
Association of British Neurologists |
| |
British Nuclear Medicine Society |
| |
College of Mental Health Pharmacy |
| |
Faculty of Public Health |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| |
UK Clinical Pharmacy Association |
| Associated public health groups |
None |
| Comparator companies |
Eisai (donepezil) (confidentiality agreement signed, participating) |
| |
Accord Healthcare (donepezil, memantine) (confidentiality agreement not signed, not participating) |
| |
Accord-UK (donepezil, galantamine, memantine) (confidentiality agreement not signed, not participating) |
| |
Aspire Pharma (galantamine) (confidentiality agreement not signed, not participating) |
| |
Aurobindo Pharma – Milpharm (donepezil, galantamine) (confidentiality agreement not signed, not participating) |
| |
Cipla (donepezil) (confidentiality agreement not signed, not participating) |
| |
Dr Reddy’s Laboratories (galantamine, memantine, rivastigmine) (confidentiality agreement not signed, not participating) |
| |
Fontus Health (galantamine) (confidentiality agreement not signed, not participating) |
| |
Genus Pharmaceuticals (memantine) (confidentiality agreement not signed, not participating) |
| |
Glenmark Pharmaceuticals (memantine) (confidentiality agreement not signed, not participating) |
| |
Kent Pharma (rivastigmine) (confidentiality agreement not signed, not participating) |
| |
Krka UK (memantine, rivastigmine) (confidentiality agreement not signed, not participating) |
| |
Lundbeck (memantine) (confidentiality agreement not signed, not participating) |
| |
Lupin Healthcare (memantine) (confidentiality agreement not signed, not participating) |
| |
Mylan (donepezil, memantine, rivastigmine) (confidentiality agreement not signed, not participating) |
| |
Novartis Pharmaceuticals (rivastigmine) (confidentiality agreement not signed, not participating) |
| |
Ranbaxy, a Sun Pharmaceutical Company (donepezil) (confidentiality agreement not signed, not participating) |
| |
Rosemont Pharmaceuticals (donepezil, memantine, rivastigmine) (confidentiality agreement not signed, not participating) |
| |
Sandoz (galantamine, rivastigmine) (confidentiality agreement not signed, not participating) |
| |
Takeda (galantamine) (confidentiality agreement not signed, not participating) |
| |
Thame Laboratories (galantamine) (confidentiality agreement not signed, not participating) |
| |
Zentiva (memantine, galantamine) (confidentiality agreement not signed, not participating |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Cambridge Public Health |
| |
National Institute for Health Research |
| |
Research Institute for the Care of Older People |